Clinical Trials
14 trialsNCT00001595 2026-05-22
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03665064 2026-03-16
Long Term Outcome Study in Patients With Pituitary Disorders
University of Alberta
Active not recruiting
NCT07268183 2026-01-22
OEMacroPrL
Hospices Civils de Lyon
Recruiting
NCT06936813 2026-01-08
The PROMISE Survey
University Hospital, Basel, Switzerland
Active not recruiting
NCT04106531 2025-12-05
Prolac-10
Ohio State University
Terminated
NCT00601289 2020-07-31
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT03474601 2020-03-18
SNU-PIT
Seoul National University Hospital
Unknown
NCT00939523 2020-01-22
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT01504399 2018-08-22
Rhinological Outcomes in Endonasal Pituitary Surgery
St. Joseph's Hospital and Medical Center, Phoenix
Completed
NCT02854228 2016-08-03
PITUICARE-Lyon
Hospices Civils de Lyon
Unknown
NCT01775332 2015-07-31
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Unity Health Toronto
Phase NA Unknown
NCT01088763 2014-11-05
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00598949 2010-12-15
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Cedars-Sinai Medical Center
Unknown